ConcertAI’s TeraRecon Integrates AI-based Chest Solutions into Eureka Clinical AI Platform through Riverain Technologies Partnership

Breadth and Depth of Integrations Across Lung Imaging Acquisition, Reading and Reporting, and Care Coordination Enhance Customer Workflow and Access CAMBRIDGE, Mass., Feb. 23, 2023 /PRNewswire/ — ConcertAI’s TeraRecon Eureka Clinical AI SaaS platform brings artificial intelligence (AI) and Deep Learning technologies to automate thoracic image interpretation...

UnitedHealthcare Provides Commercial Coverage for FoundationOne®CDx and FoundationOne®Liquid CDx in Multiple Companion Diagnostic Indications

FDA-approved FoundationOne®CDx will be the only tissue-based comprehensive genomic profiling test covered by UnitedHealthcare FDA-approved FoundationOne®Liquid CDxwill be covered for patients with advanced breast cancer, metastatic non-small cell lung cancer,...